載入...
Histone deacetylase inhibition promotes intratumoral CD8(+) T-cell responses, sensitizing murine breast tumors to anti-PD1
Histone deacetylase (HDAC) inhibitors impair tumor cell proliferation and alter gene expression. However, the impact of these changes on anti-tumor immunity is poorly understood. Here, we showed that the class I HDAC inhibitor, entinostat (ENT), promoted the expression of immune-modulatory molecules...
Na minha lista:
| 發表在: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879872/ https://ncbi.nlm.nih.gov/pubmed/31720815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02430-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|